Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-01-05

FDA Approved: SUCRALFATE ORAL SUSPENSION — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved Glenmark's generic sucralfate oral suspension via Original Application (ANDA) to provide the same indications as the reference product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SUCRALFATE ORAL SUSPENSION (SUCRALFATE)

Snippet

ORIG AP for SUCRALFATE ORAL SUSPENSION (SUCRALFATE)